Greenbrook TMS Inc
TSX:GTMS
Net Margin
Greenbrook TMS Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
|
Greenbrook TMS Inc
TSX:GTMS
|
28.6m CAD |
-89%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
90.5B USD |
1%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
80.2B USD |
2%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
68.9B EUR |
2%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.9B EUR |
5%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
25.4B EUR |
3%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23B USD |
6%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.6B USD |
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12.7B EUR |
3%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD |
6%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
9.9B USD |
10%
|
Greenbrook TMS Inc
Glance View
Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company is headquartered in Toronto, Ontario and currently employs 430 full-time employees. The company went IPO on 2018-10-03. The TMS therapy is a non-invasive therapy for the treatment of depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. The firm's patient-focused, customer service model provides TMS therapy accessible to all patients through three business processes: Patient Inquiry; Patient Conversion; and Treatment Delivery. A course of TMS consists of 36 treatments and a course of treatment consist of an initial cortical mapping and motor threshold determination and treatment, daily treatment sessions and a subsequent motor threshold re-determination and treatment. The company operates through approximately 130 Company-operated treatment centers. The company operates across the States of North Carolina, South Carolina, Maryland, Delaware, Missouri, Illinois, and Ohio.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Greenbrook TMS Inc's most recent financial statements, the company has Net Margin of -89.3%.
You don't have any saved screeners yet